dc.date.accessioned2022-01-04T20:30:01Z
dc.date.available2022-01-04T20:30:01Z
dc.date.created2022-01-04T20:30:01Z
dc.date.issued2014
dc.identifierhttps://hdl.handle.net/20.500.12866/10535
dc.identifierhttps://doi.org/10.1016/S0165-0327(14)70005-9
dc.description.abstractDepression is the predominant pole of illness disability in bipolar disorder and, compared with acute mania, has less systematic research guiding treatment development. The aim of this review is to present the therapeutic options currently available for managing bipolar depression and to highlight areas of unmet need and future research.
dc.languageeng
dc.publisherElsevier
dc.relationJournal of Affective Disorders
dc.relation1573-2517
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectBipolar
dc.subjectDepression
dc.subjectMood stabilizers
dc.subjectAntidepressants
dc.titleCurrent landscape, unmet needs, and future directions for treatment of bipolar depression
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución